Skip to main content

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

Include preview-only content
  1. Article

    Open Access

    Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

    Despite positive results from large phase III clinical trials proved that it is possible to prevent estrogen-responsive breast cancers with selective estrogen receptor modulators and aromatase inhibitors, no s...

    Matteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano in BMC Cancer (2012)

  2. Article

    Open Access

    A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

    We previously demonstrated that 1 or 5 mg per day of tamoxifen (T) given for four weeks before surgery reduces Ki-67 in breast cancer (BC) patients to the same extent as the standard 20 mg/d. Given the long ha...

    Davide Serrano, Matteo Lazzeroni, Sara Gandini, Debora Macis in Breast Cancer Research (2013)

  3. Article

    Open Access

    Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial

    Treatment of diabetics with metformin is associated with decreased breast cancer risk in observational studies, but it remains unclear if this drug has clinical antineoplastic activity. In a recent presurgical...

    Andrea DeCensi, Matteo Puntoni, Sara Gandini in Breast Cancer Research and Treatment (2014)